One of the greatest "epidemics" of our time in the western world is prematurity at the time of birth of our babies. Stress, food, sperm quality, pollution and certain other factors that we don't pay too much attention to are causing more and more premature births to occur.
Regardless of the cause, you can see a possible solution to prevent premature births, a drug called Makena. This drug has recently been approved by the FDA (Food and Drug Administration), which is the body that regulates the administration of food and drugs (drugs are drugs) in the US and its scientific name is hydroxyprogesterone caproate, also known as 17P.
Makena It is the first drug designed to prevent premature births. To date, the only thing that could be done was passive prevention (making the mother rest, avoiding efforts and gestures or acts that could cause her to give birth) and treating the woman with drugs if the labor began before of hour in order to stop it as much as possible.
The 17P, on the other hand, is administered to pregnant women without anything that has been said. It is obviously not intended for all women in a state of gestation, but only to those who have already had a premature baby in a previous pregnancy, either due to premature labor or due to a rupture of membranes. Treatment is limited to these mothers only when they are pregnant with only one baby.
The treatment consists of administering a weekly injection to the pregnant women starting between week 16 and 20 until week 37.
The objective is prevent the more premature deliveries the better to avoid complications that babies born before term can end up suffering and observing the studies seems that this is true.
In a clinical trial involving 463 pregnant women divided into two groups that had a history of spontaneous premature births, it was observed that in the group of women who received Makena 37 percent gave birth before 37 weeks, compared with 55 percent. One hundred of the women who did not receive the medicine.
